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Migration is a major risk factor for schizophrenia but the 
neurochemical processes involved are unknown. One candi-
date mechanism is through elevations in striatal dopamine 
synthesis and release. The objective of this research was to 
determine whether striatal dopamine function is elevated 
in immigrants compared to nonimmigrants and the rela-
tionship with psychosis. Two complementary case–con-
trol studies of in vivo dopamine function (stress-induced 
dopamine release and dopamine synthesis capacity) in 
immigrants compared to nonimmigrants were performed in 
Canada and the United Kingdom. The Canadian dopamine 
release study included 25 immigrant and 31 nonmigrant 
Canadians. These groups included 23 clinical high risk 
(CHR) subjects, 9 antipsychotic naïve patients with schizo-
phrenia, and 24 healthy volunteers. The UK dopamine syn-
thesis study included 32 immigrants and 44 nonimmigrant 
British. These groups included 50 CHR subjects and 26 
healthy volunteers. Both striatal stress-induced dopamine 
release and dopamine synthesis capacity were significantly 
elevated in immigrants compared to nonimmigrants, inde-
pendent of clinical status. These data provide the first evi-
dence that the effect of migration on the risk of developing 
psychosis may be mediated by an elevation in brain dopa-
mine function.
Key words:  schizophrenia/stress/positron emission 
tomography
Introduction
Geographic mobility has a large impact on sociologi-
cal, economic, and health factors within communities. 
Over 247 million people, or 3.5% of the world population, 
became migrants over the last decade.1,2 One of the most 
consistent findings in the epidemiology of schizophrenia 
is the high incidence of the disorder among immigrant 
groups (relative risk vs nonimmigrant: 2.9).3 The risk is 
particularly increased in immigrant groups who migrate 
from a country where the population is predominantly 
black skinned to a country where the population is pre-
dominantly white skinned (relative risk vs nonimmigrant: 
4.8).3 This increased risk of schizophrenia has been 
reported both in immigrants and in their children. These 
findings have been replicated in a number of high income 
countries: The Netherlands,4 Denmark,5 Germany,6 the 
United Kingdom,7 and Canada,8 clearly establishing that 
the incidence of schizophrenia is higher among migrant 
groups as compared to host populations.
Models of how social factors such as immigration lead 
to psychosis have mainly considered the role of stress.9 
Dysregulation of the stress response is a potential etio-
logical factor in the development and relapse of dopamine 
(DA)-related human disorders including drug-induced 
psychosis and schizophrenia.10,11 The stress-vulnerability 
model suggests that an endogenous, organic diathesis or 
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vulnerability interacts with internal or external stressors in 
the development of psychotic disorders.12 This includes the 
social defeat hypothesis, which suggests that social defeat 
stress may lead to psychosis through sensitization of stria-
tal DA neurotransmission.13,14 Initial studies in healthy 
volunteers have examined the impact of various forms 
of social defeat on brain function,15–18 including striatal 
DA release.17,18 Two recent studies showed that urban liv-
ing15 and immigration16 were associated with altered brain 
responses to stress, providing the first link between social 
factors and brain function. Particularly in immigrants, 
perceived discrimination of participant’s ethnic group 
predicted activation of the ventral striatum,16 an area 
with dense DA innervation. However, so far no study has 
directly investigated dopamine function in immigrants.
DA hyperactivity in the striatum is a core neurobiolog-
ical feature of schizophrenia that could underlie the exag-
gerated incidence of schizophrenia in immigrants.19–23 
Here, we tested this hypothesis directly using positron 
emission tomography (PET) in vivo in immigrants and 
their children with, or at risk for, schizophrenia. To fur-
ther validate our finding we report two complementary 
PET DA neuroimaging approaches to study two immi-
grant populations, one in Canada and one in the United 
Kingdom. The Canadian study investigated whether the 
induction of stress by a validated laboratory psychosocial 
task (Montreal Imaging Stress Task, MIST)24 elicits more 
DA release in immigrants (first and second generation) as 
compared to the host population. The UK study sought 
to confirm the association between immigration (first and 
second generation) and elevated striatal DA function in a 
different cohort using the complementary technique of 
[18F]DOPA PET to estimate DA synthesis capacity.25
Methods
Canada Study: Stress-Induced Striatal Dopamine 
Release
Participants. All subjects provided written, informed con-
sent to participate. Immigration status determined using 
the self-reported place of birth of the participants, their 
parents, and grandparents. The immigrant group (N = 26) 
included first (N = 9) and second-generation immigrants 
(N  =  8) to Canada (The generation information details 
were not available in 9 subjects, supplementary table S1). 
The nonimmigrant group (N = 31) had been in Canada for 
at least 3 generations. The immigrant and nonimmigrant 
groups were comparable for demographics (table 1).
The immigrant and nonimmigrant groups included sub-
jects at clinical high risk (CHR) for psychosis (N = 23), anti-
psychotic naïve patients with schizophrenia (SCZ, N = 9) 
and healthy volunteers (HV, N = 24) (supplementary table 
S1). The CHR subjects met criteria for prodromal syn-
dromes26 based on the Structured Interview of Prodromal 
Syndromes (SIPS)26,27 and were recruited from the early 
identification and treatment services for those who are at 
risk of psychosis (Focus on Youth Psychosis Prevention 
clinic, FYPP) at the Centre for Addiction and Mental 
Health (CAMH), Toronto, Canada. SCZ subjects were 
recruited from the first episode psychosis clinic at CAMH, 
with the diagnosis of schizophrenia and schizophreniform 
disorder, no other current Axis I  psychotic disorders, 
and no antipsychotic exposure (ie, antipsychotic naïve). 
HV were recruited from the same geographic area, had 
no personal history of psychiatric symptoms, and were 
not taking psychotropic medication. Participants from 
the current study overlapped with the cohort in previous 
dopamine imaging studies23,28,29 in whom information on 
immigration status was available. Exclusion criteria for all 
participants included pregnancy, other contra-indications 
to PET imaging and illicit drug use other than cannabis 
in the 6 months prior to imaging. The absence of illicit 
substance use other than cannabis was confirmed using 
urine drug screens at the time of PET imaging. In all par-
ticipants, the level of perceived stress was measured using 
the Trier Inventory for the Assessment of Chronic Stress.30
Montreal Imaging Stress Task. A psychological 
stress task was performed during the PET imaging ses-
sion to elicit dopamine release. Psychological stress 
was induced using the Montreal Imaging Stress Task 
(MIST) which has been validated in previous fMRI and 
PET studies15,16,23,24,28,31,32 (see supplementary e-material 
MIST section for details).
In all experiments, the control or stress task was 
started ~6–8 min before tracer injection, with 6 min of 
mathematical questions and ~1–2 min for either neutral 
or negative verbal feedback. Perception of stress during 
the control and stress conditions was assessed by a short-
ened version of the state anxiety questionnaire.23,28,33 The 
stress task was effective in producing subject-tailored fail-
ure and eliciting a stress response, which was equivalent 
across the immigrant and nonimmigrant groups (supple-
mentary figures S1 and S2).
[11C]-(+)-PHNO PET Image Acquisition. All 56 sub-
jects completed 2 PET scans (n = 112 PET scans) at least 
a week apart at the same time of the day, one while per-
forming the SMCT (sensory motor control task) and one 
while undergoing the MIST (stress task). Stress-induced 
DA release was measured using [11C]-(+)-PHNO positron 
emission tomography (PET), through quantification of 
the competition between endogenous DA and [11C]-(+)-
PHNO for D2/3 receptor binding in the striatum. The 
radiosynthesis of [11C]-(+)-PHNO has been described in 
detail elsewhere.34 Studies were carried out using a high res-
olution PET CT, Siemens-Biograph HiRez XVI (Siemens 
Molecular Imaging ).  Each subject was administered 
~333–370 MBq of high specific activity [11C]-(+)-PHNO 
and scanned for 90  min. A  custom-fitted thermoplastic 
mask was made for each subject and used with a head 
fixation system during PET acquisition to minimize head 
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movement. A  CT transmission scan was acquired after 
each emission scan for attenuation correction.
[11C]-(+)-PHNO PET Image Analysis. PET images 
were reconstructed with a 2D filtered back projection algo-
rithm with a ramp filter at Nyquist cut-off frequency and 
rebinned into 31 time frames (comprising the background 
frame, followed by [11C]-(+)-PHNO injection by fifteen 60-s 
frames and fifteen 300-s frames) as previously validated.35 
Time activity curves (TAC) from the regions of interest 
(ROIs) were obtained from the dynamic [11C]-(+)-PHNO 
PET images. The ROIs selected were the whole striatum 
and its functional subdivisions, including the associative 
(AST), limbic (LST), and sensorimotor striatum (SMST).36 
ROIs were delineated using an automated method imple-
mented in an in-house software (ROMI).37 Activity from 
bilateral ROI were combined and the volume-weighted 
average signal was used to derive [11C]-(+)-PHNO binding 
potential (BPND).
38 BPND was calculated by the Simplified 
Reference Tissue Method39 using a cerebellar reference 
region, as previously described for [11C]-(+)-PHNO.40
Stress-induced DA release was quantified as [11C]-(+)-
PHNO % displacement = (BPNDSMCT − BPND MIST) / 
BPND SMCT) × 100%.
In complement to the ROI approach, stress-induced 
DA release was also assessed using voxel-wise analysis. 
Each BPND parametric map was spatially normalized to 
the Montreal Neurological Institute (MNI) anatomical 
template using SPM2 normalization and co-registration 
tools. These maps were then used to assess significant 
contrasts between nonstress and stress conditions at the 
level of the whole brain using an implicit mask of BPND 
>0.3. This mask restricts the statistical search to areas of 
specific binding (ie, excluding cerebrospinal fluid, back-
ground, and the reference region).
UK Study: Striatal Dopamine Synthesis Capacity
Participants. All subjects provided written, informed 
consent to participate. As in the Canada study, immigra-
tion status determined using the self-reported place of 
birth of the participants, their parents, and grandparents. 
The immigrant group (N = 31) included first (N = 13) and 
second-generation (N  =  18) immigrants to the United 
Kingdom. The nonimmigrant group (N = 44) had been 
in the United Kingdom for at least 3 generations. The 
immigrant and nonimmigrant groups were comparable 
for demographics (table 2).
These participants included 50 individuals who met 
operationalized CHR criteria41 and 26 HV (supplementary 
table S2). CHR participants were recruited from Outreach 
and Support in South London (OASIS, part of the South 
London and Maudsley National Health Service Trust). Of 
the 50 CHR subjects, 2 were using antipsychotics (1 using 
olanzapine and 1 using quetiapine). The HV group was 
recruited from the same geographic area and had no per-
sonal of psychiatric symptoms, or psychotropic medica-
tion. Both the CHR and HV groups included subjects who 
had participated in previous dopamine imaging studies19,21 
where information on immigration status was available. 
Exclusion criteria for all participants included pregnancy 
or other contra-indications to PET imaging. The absence 
of illicit substance use other than cannabis was confirmed 
by urine drugs screen at the time of PET imaging.
[18F]-DOPA PET Image Acquisition. Studies were car-
ried out using either a CTI/Siemens ECAT HR+ 962 
tomograph (16 HV; 26 CHR)19 or a CTI/Siemens ECAT 
HR++ 966 tomograph (10 HV; 24 CHR)21 (Siemens 
Molecular Imaging). All participants were asked to fast 
for 12 h before imaging and received carbidopa (150 mg) 
and entacapone (400  mg) orally 1  h before imaging to 
Table 1. Demographic Data by Immigration Status for the Stress-
Induced DA Release Study, Canada Site
Demographics
Nonimmigrant,  
n = 30
Immigrant,  
n = 26
Age, years; mean (SD) 25.00 (4.86) 23.85 (4.49)
Education, years; mean (SD) 14.00 (2.12) 14.08 (2.53)
Ethnicity 1/2/3/4/5 28/0/0/1/1 6/0/14/4/2
Clinical status
 HV 17 7
 CHR 9 14
 SCZ 4 5
Gender
 Male 18 14
 Female 12 12
Tobacco smoking status
 Nonsmoker 21 23
 Smoker 9 3
Cannabis
 Nonuser 14 15
 User (current) 16 11
Cocaine
 Nonuser 26 22
 User (previous) 4 4
Amphetamine
 Nonuser 28 26
 User (previous) 2 0
Ecstasy
 Nonuser 24 22
 User (previous) 6 4
Amount injected (MBq)
 Control task 358.16 (38.11) 343.36 (70.67)
 Stress task 364.82 (31.08) 367.04 (38.85)
Specific activity (MBq/nmol)
 Control task 43.32 (18.55) 39.22 (18.99)
 Stress task 47.82 (18.68) 41.76 (18.12)
Mass injected (µg)
 Control task 2.30 (0.82) 2.38 (0.85)
 Stress task 2.12 (0.85) 2.56 (0.81)
Note: SD, standard deviation; HV, healthy volunteer; CHR, 
clinical high risk; SCZ, schizophrenia; Ethnicity (self-reported): 1: 
White; 2: mixed/multiple ethnic groups; 3: Asian/Asian Canadian; 
4: Black/African/Caribbean/Black Canadian; 5: Other. There are 
no significant group differences.
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reduce the formation of radiolabeled [18F]-DOPA metabo-
lites. Data were acquired in three-dimensional mode while 
participants lay at rest. Transmission scans performed 
before radiotracer injection corrected for attenuation and 
scatter. Head position was minimized using a light head 
strap. [18F]-DOPA was administered by bolus intravenous 
injection (supplementary table S2). Emission data were 
acquired in list mode for 95 min, and rebinned into 26 time 
frames (comprising the 30-s background frame, followed 
by [18F]-DOPA injection with four 60-s frames, three 120-s 
frames, three 180-s frames, and fifteen 300-s frames).
[18F]-DOPA PET Image Analysis. Data were recon-
structed using the 3D reprojection algorithms. To correct 
for head movement during the scan, nonattenuation-cor-
rected dynamic images were denoised using a level 2, order 
64 Battle-Lemarie wavelet filter42 and individual frames 
were realigned using a mutual information algorithm.43 
The transformation parameters were then applied to the 
corresponding attenuation-corrected frames, and the 
realigned frames were combined to create a movement-
corrected dynamic image for analysis.
Striatal ROI were delineated bilaterally on a single sub-
ject T1 MRI in MNI space. The cerebellar reference region 
was defined using a probabilistic atlas.44 An [18F]-DOPA 
template, also in MNI space, was then normalized together 
with the ROI map to each individual PET summation 
image using SPM5.25 Graphical analysis, adapted for a ref-
erence tissue input function45,46 was used to estimate pre-
synaptic dopamine synthesis capacity by calculating the 
rate of utilization of the dopamine precursor 18F-DOPA 
(ki
cer min−1) in the bilateral striatum. To control for poten-
tial effects of scanner model,19 individual subject ki
cer val-
ues were converted to z-scores [z =  (ki
cer – scanner mean 
ki
cer) / scanner standard deviation (SD)] for all analyses.
Statistical Analysis
Analysis of covariance was used to determine the main 
effects of immigration status and of clinical group on 
[11C]-(+)-PHNO displacement or 18F-DOPA z-score 
in the striatum. Nonsignificant immigration × clinical 
group interaction terms were subsequently removed from 
the model. Effect sizes were calculated as partial eta2. 
Follow-up analysis co-varied for potential effects of illicit 
drug use. The voxel-wise analysis of DA release utilized 
SPM8 to examine the difference between the control and 
stress conditions using paired t-tests in the immigrant and 
nonimmigrant groups, with cannabis use and clinical status 
as covariates. Partial correlation examined the relationship 
between perceived stress and [11C]-(+)-PHNO displace-
ment, co-varying for clinical status (n = 54). Statistical sig-
nificance was defined as P < .05 unless otherwise stated.
Results
Canada Study: Stress-Induced Striatal Dopamine 
Release
[11C]-(+)-PHNO BPND values in the control and stress 
conditions are provided in the supplementary table S3. 
Immigrants demonstrated elevated striatal DA release in 
response to stress compared to nonmigrant Canadians 
(F = 8.08; df = 1, 52; P = .006; partial eta2 = 0.13) (figure 1). 
The clinical group effect was significant (F = 3.57; df = 1, 
52; P = .04; partial eta2 = 0.12), as patients with schizo-
phrenia showed higher striatal DA release than CHR and 
HV (Bonferroni corrected comparisons, P = .05 and .02, 
respectively). However, the clinical group by immigration 
status interaction term was nonsignificant. The signifi-
cant increase in stress-induced DA release in immigrants 
was present in the AST (F = 8.05; df = 1, 52; P =  .006; 
partial eta2 = 0.13; figure 1), LST (F = 5.22; df = 1, 52; 
P = .03; partial eta2 = 0.09), and SMST (F = 4.17; df = 1, 
52; P = .05; partial eta2 = 0.07). Voxel-wise analysis also 
revealed significant stress-induced striatal DA release in 
immigrants (supplementary figure S3) with no significant 
effect in nonimmigrants.
Secondary exploratory ANOVA comparing nonimmi-
grants to first and second generation immigrants sepa-
rately found an overall significant effect of immigration 
Table 2. Demographic Data by Immigration Status for the DA 
Synthesis Study, UK Site
Demographics
Nonimmigrant,  
n = 44
Immigrant,  
n = 32
Age, years; mean (SD) 24.61 (4.54) 23.25 (4.14)
Ethnicity 1/2/3/4/5 35/2/0/7/0 9/2/5/16/0
Clinical status
 HV 13 13
 CHR 31 19
Gender
 Male 29 15
 Female 15 17
Tobacco smoking status
 Nonsmoker 24 20
 Smoker 19 13
Cannabis
 0/1/2/3/4 12/14/5/6/7 10/11/4/4/3
Cocaine
 0/1/2/3/4 26/12/3/2/1 23/5/1/2/1
Amphetamine
 0/1/2/3/4 30/12/1/1/0 28/3/0/1/0
Ecstasy
 0/1/2/3/4 21/18/3/2/0 24/4/3/1/0
Injected dose (MBq) 166.41 (16.20) 163.97 (18.21)
Specific activity (MBq/μM) 26.09 (13.94) 28.28 (16.70)
Note: SD, standard deviation; HV, healthy volunteer; CHR, 
clinical high risk; SCZ, schizophrenia; Ethnicity (self-reported): 
1L White; 2L Mixed/multiple ethnic groups; 3: Asian/Asian 
Canadian; 4: Black/African/Caribbean/Black Canadian; 5: 
Other. Drug use is denoted 0: never used; 1: very occasional 
or experimental use; 2: occasional (monthly) use; 3: moderate 
(weekly) use; 4: severe (daily) use. There are no significant group 
differences.
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on striatal DA release (F = 3.31; df = 2, 44; P =  .046), 
with post hoc tests indicating this was primarily driven by 
elevated striatal DA release in the first generation immi-
grants compared to the nonimmigrant group (Bonferroni 
corrected comparisons, P = .05), whereas stress induced 
DA release did not differ significantly between second 
generation immigrants and nonimmigrants (P = .68) or 
first generation immigrant groups (P = 1.00).
When the ROI analysis was repeated with cannabis use 
included as a covariate, the effects of both immigration 
(F = 7.26; df = 1, 51; P = .01) and clinical group (F = 3.68; 
df = 2, 51; P = .03) remained significant across the whole 
striatum. The immigration effect remained significant in 
AST (F = 7.23; df = 1, 51; P = .01) and LST (F = 4.48; 
df = 1, 51; P = .04), and trend level in SMST (F = 3.51; 
df  =  1, 51; P  =  .07). The clinical group effect was also 
significant in AST (F  =  5.15; df  =  1, 51; P  =  .01), and 
was present at trend-level in SMST (F = 2.81; df = 2, 51; 
P = .07), but not in LST. The effects of immigration and 
clinical group on DA release also remained after co-vary-
ing for lifetime history of previous use of other illicit drugs 
(table 1). Stress-induced striatal DA release was associated 
with several measures of social stress, including work over-
load, social overload, social pressure, social isolation, etc. 
(supplementary table S1 and supplementary figure S4).
UK Study: Striatal Dopamine Synthesis Capacity
Striatal DA synthesis capacity was elevated in the immi-
grant compared to the nonimmigrant group (F  =  4.95; 
Fig. 1. (A) Significant effect of immigration on stress induced DA release in the whole striatum and in striatal subdivisions, including 
AST, LST, and SMST. WS (F = 8.08; df = 1, 52; P = .006), AST (F = 8.05; df = 1, 52; P = .006), LST (F = 5.22; df = 1, 52; P = .03), and 
SMST (F = 4.17; df = 1, 52; P = .05). (B) Effects of immigration on stress-induced dopamine release in the whole striatum by clinical 
vulnerability (mean and standard error of the mean, SEM).
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df = 1, 73; P = .03, partial eta2 = 0.06, figure 2). The clini-
cal group effect showed a trend for increased DA synthe-
sis in the CHR compared to HV group (F = 3.79; df = 1, 
73; P =  .06; partial eta2 = 0.05). The clinical group by 
immigration status interaction term was nonsignificant. 
The significant elevation in DA synthesis capacity in 
immigrants was present in the SMST (F = 9.24; df = 1, 73; 
P = .003; partial eta2 = 0.11), with a similar trend in the 
AST (F = 3.28; df = 1, 73; P = .07; partial eta2 = 0.04). 
Secondary exploratory ANOVA comparing nonimmi-
grants to first and second generation immigrants sepa-
rately found an overall significant effect of immigration 
on striatal dopamine synthesis capacity (F = 3.12; df = 1, 
73; P = .047), with post hoc tests indicating this was pri-
marily driven by elevated DA synthesis capacity in the 
second generation immigrant compared to nonimmigrant 
Fig. 2. (A) Significant effect of immigration on DA synthesis capacity in the whole striatum and SMST, with similar trends in the 
AST. WS (F = 4.95; df = 1, 73; P = .03), SMST (F = 9.24; df = 1, 73; P = .003), and AST (F = 3.28; df = 1, 73; P = .07). (B) Effects of 
immigration on DA synthesis capacity in the whole striatum by clinical vulnerability (mean and standard error of the mean, SEM).
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group (P = .04), whereas DA synthesis capacity did not 
differ significantly between first generation immigrant 
and nonimmigrant (P = .91) or second generation immi-
grant groups (P = .23).
When cannabis use was included in the model, the main 
effects of both immigration and clinical status on DA 
synthesis capacity were significant for the whole striatum 
(F = 4.83; df = 1, 72; P = .03 and F = 4.35; df = 1, 72; P = .04, 
respectively). The immigration effect remained significant in 
SMST (F = 9.06; df = 1, 72; P = .004) and trend level in AST 
(F = 3.18; df = 1, 72; P = .07). The clinical group effect was 
significant in AST (F = 4.56; df = 1, 72; P = .04). The main 
effects of immigration and clinical group on DA synthesis 
also remained after co-varying for previous use of other 
illicit substances (table 2), or after excluding the 2 CHR sub-
jects who were currently taking antipsychotics.
Discussion
These results indicate that striatal DA function is elevated 
in both immigrants and their children, including those at 
risk for psychosis or with schizophrenia, confirming its 
relevance for psychotic disorders. The elevation in DA in 
immigrants was present with relatively large effect size 
in both the Canada and UK studies, which were per-
formed in independent samples using 2 complementary 
approaches to imaging presynaptic DA function. As in 
previous studies of schizophrenia,21 elevated DA in immi-
grants were most evident in dorsal striatal regions (AST 
and SMST). This suggests that adverse psychological, 
social, and environmental experiences associated with 
immigration may increase the risk of schizophrenia by 
influencing brain dopamine function, a key pathophysi-
ological component of psychosis.
The increased DA function in immigrants and their 
children did not appear to be influenced by cannabis 
exposure.28,47 In both experiments, we confirmed the 
absence of illicit drugs other than cannabis at the time of 
PET imaging by urine drugs screen. There were no sig-
nificant differences in self-reported drug use and immi-
gration effects remained significant when previous illicit 
drug use was included in the analyses. While lack of 
detailed illicit drug histories or hair analyses is a limita-
tion, from the available data we believe that our findings 
were unlikely to be related to drug use. As both the UK 
and Canadian cohorts included participants of multiple 
ethnic groups and different generation (1st vs 2nd) distri-
bution, we were unable to determine the effects of immi-
gration accounting for ethnicity or generation status. 
Future studies could focus on the impact of ethnicity and 
immigration generation on dopamine function.
While the reasons for the increased risk of schizo-
phrenia and other psychoses in migrant groups are still 
unclear, there is increasing evidence that victimization, 
discrimination, social isolation, social defeat, and grow-
ing up in an urban environment may contribute.17,48,49,50 
Our subjects came from 2 large cities (London, UK and 
Toronto, Canada) with relatively large immigrant popu-
lations. One avenue for future research is the extent by 
which social support interventions can mitigate the rela-
tionship between risk factors such as immigration, neu-
robiological markers, and poor mental health. Given the 
significant waves of immigration happening at this time 
both in Europe and the Americas, these interventions 
may become key as pre-emptive strategies.
Cross-sectional studies such as ours cannot pro-
vide causal information about the associations between 
immigration, elevated dopamine function, and schizo-
phrenia. However, studies in experimental animals have 
shown that experiences of social defeat stress can lead to 
striatal DA elevation.51 More broadly, our data are con-
sistent with hypotheses linking social defeat to elevated 
DA and schizophrenia,13,14,52,53 and reports of striatal DA 
elevations in adults with hearing impairment,17 history of 
childhood abuse18 or low parental care,24 which may all be 
forms of social defeat/stress. Our study further supports 
the relevance of the interaction between adverse social 
factors and striatal DA for psychotic disorders.
Conclusions
The data from the present study identify a plausible bio-
logical mechanism that links the effects of migrant sta-
tus to the risk of developing psychosis through elevated 
brain dopaminergic function. These findings suggest that 
interventions designed to reduce the psychosocial impact 
of being a migrant might be useful as a means of reduc-
ing the risk of psychotic illness.
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